KarinaSoto PortugalCentro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de Lisboa

KarinaSoto
Karina Soto, MD, PhD Certification and Licensure M.D. Degree in Medicine from the Catholic University of Córdoba, Argentina. Specialization in Nephrology Certification from the Faculty of Medicine, University of São Paulo (FMUSP). Residency in the Hospital das Clínicas, Brazil. Master in Transplant Coordination by the National Transplant Organization of the Ministry of Health of Spain and the Universidad Autónoma de Barcelona PhD in Medicine and Surgery from the Faculty of Medicine of the Universidad Autónoma de Madrid, Spain Specialty in Nephrology Certification by the Nephrology Specialty College of the Ordem dos Médicos, Lisbon, Portugal Competence in Health Services Management: PADIS by AESE Business School Current Appointments and Positions (main) Director of Nephrology Department – Unidade Local de Saúde de Arrábida, EPE. Affiliated Research Scientist na Nova Medical School/Faculdade de Ciências Médicas da Universidade Nova de Lisboa, Member of the INOVA4Health Unit Member of the Health Technology Assessment Committee, Infarmed in Portugal Member of the OncoNephrology and Translational Nephrology groups at SPN and GLOSEN in Spain Research Activities Several Clinical and Transitional Research responsibilities and activities, since 1995 in Spain and Portugal Research, grants, awards and publications details in: ORCID 0000-0002-6977-9361 - https://orcid.org/my-orcid?orcid=0000-0002-6977-9361 Research interest: AKI, Glomerulopathies, Monoclonal Gammopathies, Nephrotoxicity, OncoNephrology and Kidney Disease Biomarkers. This research has been funded through FCT, SPN and other peer reviewed agencies. National and international lectures on the topics of research interest. Teaching Committed to training and mentorship, KS has been continuing serving as mentor for pre-doctoral research fellows, Nephrology Residents and Internal Medicine and General Practitioner physicians during the internship in Nephrology.
Institution

Day 1 - Sunday April 14, 2024

Time Session
12:15 p.m.
1:15 p.m.
CHAL02
JavierDe Arteaga Chairperson javierdearteaga@gmail.comArgentinaHospital Privado Universitario de Cordoba. Catholic University from Cordoba
KarinaSoto Chairperson ksoto.nefro@gmail.comPortugalCentro Hospitalar de Setubal, EPE and CEDOC Universidade Nova de Lisboa
SandraHerrmann Chairperson herrmann.sandra@mayo.eduUnited StatesMayo Clinic
  • AKI-related Cancer and Cancer Treatment-related TMA
    ClaraGarcía Carro Speaker claragarciacarro@hotmail.comSpainSan Carlos Clinical Hospital (Madrid, Spain)
  • AKI Related to Cancer Immunotherapy: Can Biomarkers Help?
    SebastianLapman Speaker lapseba@yahoo.com.arArgentina
  • Magnesium and AKI: Is There a Connection? From Bench to Bedside - What We Can Learn from Onconephrology
    JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
  • Q and A
Hall E

Day 2 - Monday April 15, 2024

Time Session
12:15 p.m.
1:15 p.m.
SK04
MartaAdragna Chairperson marta.adragna@gmail.comArgentina
MoumitaBarua Chairperson moumita.barua@uhn.caCanada
  • Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? - All Patients
    Albertien M.Van Eerde Speaker NetherlandsDepartment of Genetics, UMC Utrecht, The Netherlands
  • Hot Debate: Genetic Testing in CKD: In High-risk Populations Only or in All Patients with CKD? High-risk Populations Only
    HilaMilo Rasouly Speaker Hila.MiloRasouly@columbia.eduUnited StatesColumbia University
Hall A
4:30 p.m.
5:30 p.m.
CHAL05
CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caCanadaUniversité de Montréal
Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina
  • MGRS: Should All Forms Need Clonal Therapy?
    FrankBridoux Speaker f.bridoux@chu-poitiers.frFranceDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, France
  • Renal Amyloidosis: What Is New?
    Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brBrazilSão Paulo State Cancer Institute - University of São Paulo
  • Can We Perform a Transplant in Patients with Myeloma and Amyloidosis?
    SabineKaram Speaker United StatesUniversity of Minnesota
  • Q and A
Hall A